ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984

CTRC, UCLA Receive Gifts; NCCF Distributes Gold Pins.

March 24, 2000

DePinho’s Letter to the AAUP

May 30, 2014

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978

In Brief: Cancer Center Scientist Set For Space Launch; NIH French Anderson Negotiating With USC

June 5, 1992